Wenche Rolfsen

Biography

Wenche Rolfsen has 30 years of experience in senior positions in preclinical research and development at Pharmacia. She was responsible for the early clinical organization at Quintiles Europe and CEO of Quintiles Scandinavia for a total of 11 years. She also has extensive experience from board positions in listed companies and is a member of the board of Swedish Match AB and Recipharm AB, among others. Pharmacist, Doctor of Pharmacology, Adjunct Professor at Uppsala University. Wenche Rolfsen is chairman of the board of Sarsia Seed Fund, InDex Pharmaceuticals AB, InDex Pharmaceuticals Holding AB and board member of Swedish Match AB, Recipharm AB and InDex Diagnostics AB. Wenche Rolfsen is also CEO and board member of Rolfsen Consulting AB and partner in Serendipity Partners. During the last five years Wenche Rolfsen has been CEO of InDex Pharmaceuticals AB, chairman of the board of Aprea Therapeutics AB, Denator AB, Aprea Personal AB, Smartfish AB and board member of Moberg Pharma AB, TFS Trial Form Support International AB and Apotek Produktion & Laboratorier AB.

Research Interest

Business Development and Pharmacology.